FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism

被引:132
|
作者
Wu, Ruifan [1 ]
Liu, Youhua [1 ]
Yao, Yongxi [1 ]
Zhao, Yuanling [1 ]
Bi, Zhen [1 ]
Jiang, Qin [1 ]
Liu, Qing [1 ]
Cai, Min [1 ]
Wang, Fengqin [1 ]
Wang, Yizhen [1 ]
Wang, Xinxia [1 ]
机构
[1] Zhejiang Univ, Key Lab Anim Nutr & Feed Sci, Zhejiang Prov Lab Feed & Anim Nutr, Coll Anim Sci,Minist Agr, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
FTO; Adipogenesis; m(6)A methylation; Cell cycle; YTHDF2; MESSENGER-RNA TRANSLATION; M(6)A RNA; BINDING-PROTEIN; OBESITY; METHYLATION; GENE; METABOLISM; ALKBH5;
D O I
10.1016/j.bbalip.2018.08.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N-6-methyladenosine (m(6)A) is the most prevalent internal mRNA modification in eukaryotes. Loss of m(6)A demethylase FTO increases m(6)A levels and inhibits adipogenesis of preadipocytes. However, its underlying mechanism remains elusive. Here, we demonstrated that silencing FTO inhibited adipogenesis of preadipocytes through impairing cell cycle progression at the early stage of adipogenesis. FTO knockdown markedly decreased the expression of CCNA2 and CDK2, crucial cell cycle regulators, leading to delayed entry of MDI-induced cells into G2 phase. Furthermore, the m(6)A levels of CCNA2 and CDK2 mRNA were significantly upregulated following FTO knockdown. m(6)A-binding protein YTHDF2 recognized and decayed methylated mRNAs of CCNA2 and CDK2, leading to decreased protein expression, thereby prolonging cell cycle progression and suppressing adipogenesis. Our work unravels that FTO regulates adipogenesis by controlling cell cycle progression in an m(6)A-YTHDF2 dependent manner, which provides insights into critical roles of m(6)A methylation in adipogenesis.
引用
收藏
页码:1323 / 1330
页数:8
相关论文
共 50 条
  • [1] FTO regulates ocular angiogenesis via m6A-YTHDF2-dependent mechanism
    Shan, Kun
    Zhou, Rong-mei
    Xiang, Jun
    Sun, Ya-nan
    Liu, Chang
    Lv, Meng-wei
    Xu, Jian-jiang
    EXPERIMENTAL EYE RESEARCH, 2020, 197
  • [2] FTO promotes innate immunity by controlling NOD1 expression via m6A-YTHDF2 manner in teleost
    Geng, Shang
    Zheng, Weiwei
    Zhao, Yan
    Xu, Tianjun
    ISCIENCE, 2022, 25 (12)
  • [3] FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner
    Deng, Kaiping
    Zhang, Zhen
    Ren, Caifang
    Liang, Yaxu
    Gao, Xiaoxiao
    Fan, Yixuan
    Wang, Feng
    EXPERIMENTAL CELL RESEARCH, 2021, 401 (02)
  • [4] Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner
    Ruifan Wu
    Yongxi Yao
    Qin Jiang
    Min Cai
    Qing Liu
    Yizhen Wang
    Xinxia Wang
    International Journal of Obesity, 2018, 42 : 1378 - 1388
  • [5] Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner
    Wu, Ruifan
    Yao, Yongxi
    Jiang, Qin
    Cai, Min
    Liu, Qing
    Wang, Yizhen
    Wang, Xinxia
    INTERNATIONAL JOURNAL OF OBESITY, 2018, 42 (07) : 1378 - 1388
  • [6] MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism
    Jiang, Qin
    Sun, Baofa
    Liu, Qing
    Cai, Min
    Wu, Ruifan
    Wang, Fengqin
    Yao, Yongxi
    Wang, Yizhen
    Wang, Xinxia
    FASEB JOURNAL, 2019, 33 (02): : 2971 - 2981
  • [7] FTO-dependent m6A regulates muscle fiber remodeling in an NFATC1-YTHDF2 dependent manner
    Wang, Wengang
    Du, Xueming
    Luo, Ming
    Yang, Ningning
    CLINICAL EPIGENETICS, 2023, 15 (01)
  • [8] FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner*
    Zhou, Shi-meng
    Li, Jing-zhi
    Chen, Hong-qiang
    Zeng, Yong
    Yuan, Wen-bo
    Shi, Yu
    Wang, Na
    Fan, Jun
    Zhang, Zhe
    Xu, Yuanyuan
    Cao, Jia
    Liu, Wen-bin
    ENVIRONMENTAL POLLUTION, 2023, 325
  • [9] FTO-dependent m6A regulates muscle fiber remodeling in an NFATC1–YTHDF2 dependent manner
    Wengang Wang
    Xueming Du
    Ming Luo
    Ningning Yang
    Clinical Epigenetics, 15
  • [10] Metformin combats obesity by targeting FTO in an m6A-YTHDF2-dependent manner
    Liao, Xing
    Liu, Jiaqi
    Chen, Yushi
    Liu, Youhua
    Chen, Wei
    Zeng, Botao
    Liu, Yuxi
    Luo, Yaojun
    Huang, Chaoqun
    Guo, Guanqun
    Wang, Yizhen
    Wang, Xinxia
    JOURNAL OF DRUG TARGETING, 2022, 30 (09) : 983 - 991